Spring 2023
Psychedelic Integration Clinical Consultation Group

This group will meet weekly for 12 weeks, and will keep the same members for the 12 week period. We will be learning the principles of Psychedelic Integration and methods for working with psychedelic experiences into ongoing psychotherapies. Members will be asked to present case material from their own practices once or twice during the group, and guided discussion will be encouraged. This group will be a supportive environment with the same confidentiality parameters as a psychotherapy group, and invites personal sharing, but is not a venue for therapists to discuss underground work with psychedelics that they may have done as a therapist. The group is open to practicing, licensed clinicians of all persuasions, but will emphasize psychological and psychodynamic perspectives, including discussions of transference and countertransference. We are asking CCG members to commit 12 week’s participation upon registration; it is not a drop-in group.

A limited number of diversity scholarships are available, please complete this application, in addition to the course application.

• Describe the motivations for which patients seek Psychedelic Integration Therapy.
• Assess and verbalize the complex motivations of patients to seek out and use psychedelics.
• Demonstrate how to offer nonjudgmental curiosity to the variety of subjective experiences and emotions patients report with psychedelics.
• Describe and acknowledge therapist reactions to patients who are seeking psychedelic experiences.
• Describe the importance of showing equal esteem to psychedelic experiences that are thoughtful and growth-oriented and ones that are recreational, spontaneous, or dissociative.
• Assess and articulate how psychedelics can amplify transference.
• Assess and articulate how transferences to psychedelics can become fused with therapist transferences.
• Describe how to assess for shifts in language, meaning, and self-concept that may accompany experiences with psychedelics.
• List the benefits of explaining openly (in appropriate settings) about emotional responses (countertransference) to patient reports as they relate to the therapist’s own relationship to psychedelic therapy.
• List the states of psychic disruption that suggest a need for more intensive treatment.
• Describe extended support services for the patient, including family or community resources.
• Describe how to plan the guidance and support of non-drug self-transformation efforts as part of Psychedelic Integration Therapy.

• Fluence International, Inc. is approved by the American Psychological Association to sponsor continuing education for psychologists. Fluence maintains responsibility for this program and its content.
• Fluence International, Inc. is recognized by the New York State Education Department’s State Board for Mental Health Practitioners as an approved provider of continuing education for licensed mental health counselors. #MHC-0232.
• Fluence International, Inc. is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0674.
• Fluence International, Inc. is recognized by the New York State Education Department’s State Board for Psychology as an approved provider of continuing education for licensed psychologists #PSY-0167.
• The Department’s approval of a provider of continuing education does not constitute the Department’s endorsement of the content, positions or practices that may be addressed in any specific continuing education course offered by the approved provider.
• For questions about receiving your CE/CME Certificate or Certificate of Attendance, contact Selah Drain, selah@fluencetraining.com.